We are excited to announce that our President and CEO Ellen Matloff has been invited to be a panelist at the FDA’s upcoming March 2 public workshop titled “Patient and Medical Professional Perspectives on the Return of Genetic Test Results.” She will speak on Panel 1: Well Patient tests/Predictive tests. This panel will focus on the results of genetic tests in settings like prenatal and pediatric care.

The purpose of the larger workshop is to understand patient and provider perspectives on receiving genetic test results. The topics to be discussed will focus on better defining the specific information patients and providers prefer to receive, how those results should be returned, and what information is needed to understand the results so that they may effectively aid in medical decision making.

This event is open to the public and can also be streamed live via webcast from anywhere. Get the details here.